MT-TL1 Gene MELAS Syndrome MT-TL1 Related Genetic Test
Test Name: MT-TL1 Gene MELAS Syndrome MT-TL1 Related Genetic Test
Components: MT-TL1 gene analysis
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: Next-Generation Sequencing (NGS) Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical history of patient who is going for MT-TL1 Gene MELAS syndrome, MT-TL1 related NGS Genetic DNA Test. A genetic counseling session to draw a pedigree chart of family members affected with MT-TL1 Gene MELAS syndrome, MT-TL1 related.
Test Details
The MT-TL1 gene is associated with a mitochondrial disorder called MELAS syndrome, which stands for Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes. MELAS syndrome is a rare genetic disorder that affects multiple systems in the body, particularly the brain and muscles.
The MT-TL1 gene is responsible for encoding a specific transfer RNA (tRNA) molecule involved in protein synthesis within mitochondria. Mutations in this gene can lead to a deficiency in the tRNA molecule, resulting in impaired mitochondrial function and energy production.
To diagnose MELAS syndrome and identify mutations in the MT-TL1 gene, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of MELAS syndrome, the NGS test would specifically target the MT-TL1 gene to identify any pathogenic mutations.
NGS genetic testing can provide valuable information about the presence of mutations in the MT-TL1 gene, which can help confirm a diagnosis of MELAS syndrome. This information can also be used for genetic counseling, as it can provide insight into the risk of passing the condition onto future generations. Additionally, NGS testing can help guide treatment decisions and management strategies for individuals with MELAS syndrome.
| Test Name | MT-TL1 Gene MELAS syndrome MT-TL1 related Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MT-TL1 Gene MELAS syndrome, MT-TL1 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MT-TL1 Gene MELAS syndrome, MT-TL1 related |
| Test Details | MT-TL1 gene is a gene associated with a mitochondrial disorder called MELAS syndrome. MELAS stands for Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes. It is a rare genetic disorder that affects multiple systems in the body, particularly the brain and muscles. The MT-TL1 gene is responsible for encoding a specific transfer RNA (tRNA) molecule involved in protein synthesis within mitochondria. Mutations in this gene can lead to a deficiency in the tRNA molecule, resulting in impaired mitochondrial function and energy production. To diagnose MELAS syndrome and identify mutations in the MT-TL1 gene, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of MELAS syndrome, the NGS test would specifically target the MT-TL1 gene to identify any pathogenic mutations. NGS genetic testing can provide valuable information about the presence of mutations in the MT-TL1 gene, which can help confirm a diagnosis of MELAS syndrome. This information can also be used for genetic counseling, as it can provide insight into the risk of passing the condition onto future generations. Additionally, NGS testing can help guide treatment decisions and management strategies for individuals with MELAS syndrome. |
